Literature DB >> 18329552

Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.

Volker Ruppert1, Thomas Meyer, Sabine Pankuweit, Thuridur Jonsdottir, Bernhard Maisch.   

Abstract

The coxsackievirus-adenovirus receptor (CAR) was originally described as a transmembrane protein involved in viral infection and was later found to be required for normal heart development. However, the role of CAR in virus-induced myocarditis has not been investigated so far. The purpose of this study was to assess myocardial CAR expression in response to cytokine-induced inflammatory reactions during the course of coxsackievirus-induced myocarditis. In Balb/c mice intraperitoneally infected with either 2x10(4) plaque-forming units (PFUs) of coxsackie B3 virus (CVB3) or 10(2) PFUs CVB3, CAR expression and tyrosine phosphorylation of signal transducer and activator of transcription 1 (STAT1), a known cytokine-inducible transcription factor involved in viral defense, were determined. Our results demonstrated that within the first 7 days after virus inoculation, when the viral replication and STAT1 activation in the heart tissue was most prominent, the expression of CAR did not surpass that of uninfected controls. However, the up-regulation of CAR was observed 9 weeks later, when enteroviral RNA was no longer detectable and activation of STAT1 had already ceased. In contrast to the STAT1 target genes Mig and Irf1, interferon gamma stimulation failed to up-regulate Car expression in isolated cardiomyocytes. In human endomyocardial biopsies, Car expression was found to be elevated in approximately one third of patients with dilated cardiomyopathy (9 of 30 patients) as compared with controls. Thus, activation of STAT1 clearly precedes the enhanced CAR expression observed during tissue reorganization, suggesting an essential role of STAT1 transcription factors in orchestrating the sequential actions involved in adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18329552     DOI: 10.1016/j.carpath.2007.07.004

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  6 in total

1.  Adenovirus transduction: More complicated than receptor expression.

Authors:  Priyanka Sharma; Prithy C Martis; Katherine J D A Excoffon
Journal:  Virology       Date:  2016-12-31       Impact factor: 3.616

2.  Expression of coxsackievirus and adenovirus receptor and its cellular localization in myocardial tissues of dilated cardiomyopathy.

Authors:  Tripta Kaur; Baijayantimala Mishra; Uma Nahar Saikia; Mirnalini Sharma; Ajay Bahl; Radha Kanta Ratho
Journal:  Exp Clin Cardiol       Date:  2012

3.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

Review 4.  Molecular signatures and the study of gene expression profiles in inflammatory heart diseases.

Authors:  V Ruppert; B Maisch
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation.

Authors:  Tomoko Machino-Ohtsuka; Kazuko Tajiri; Taizo Kimura; Satoshi Sakai; Akira Sato; Toshimichi Yoshida; Michiaki Hiroe; Yasuhiro Yasutomi; Kazutaka Aonuma; Kyoko Imanaka-Yoshida
Journal:  J Am Heart Assoc       Date:  2014-11-05       Impact factor: 5.501

6.  Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality.

Authors:  Bärbel Kraut; Harald J Maier; Enikö Kókai; Katja Fiedler; Thomas Boettger; Annett Illing; Sawa Kostin; Paul Walther; Thomas Braun; Thomas Wirth
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.